Aurora Cannabis, Vectura Fertin announce launch of Luo CBD lozenge

Aurora Cannabis and Vectura Fertin Pharma announce the launch of the newly developed Luo CBD lozenge. Miguel Martin, CEO for Aurora said: “As the leading provider of medical cannabis in Canada, the launch of the newly developed Luo CBD lozenge on our platform is a significant and exciting milestone at the beginning of our strategic collaboration with Vectura Fertin Pharma. We are committed to bringing innovative solutions to patients and this launch reinforces our position at the forefront of Canada’s medical cannabis industry.”